Hot Pursuit     06-Feb-25
Dr Reddys Laboratories Ltd up for third consecutive session
Dr Reddys Laboratories Ltd is quoting at Rs 1241.5, up 1.14% on the day as on 12:49 IST on the NSE. The stock is up 0.45% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

Dr Reddys Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 1241.5, up 1.14% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.41% on the day, quoting at 23600.05. The Sensex is at 77920.62, down 0.45%. Dr Reddys Laboratories Ltd has slipped around 8.14% in last one month.

Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has slipped around 5.07% in last one month and is currently quoting at 21868.5, up 0.83% on the day. The volume in the stock stood at 13.75 lakh shares today, compared to the daily average of 20.88 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 1237.6, up 1.05% on the day. Dr Reddys Laboratories Ltd is up 0.45% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

The PE of the stock is 19.77 based on TTM earnings ending December 24.

Previous News
  Dr Reddys announces change in senior management
 ( Corporate News - 10-Nov-25   19:00 )
  Dr. Reddy’s, Shaily Engineering tumble after delay in Semaglutide approval
 ( Hot Pursuit - 30-Oct-25   10:25 )
  Dr Reddys Laboratories
 ( Results - Analysis 25-Oct-25   12:51 )
  Dr Reddys Lab Q2 PAT jumps 7% YoY to Rs 1,347 cr
 ( Hot Pursuit - 25-Oct-25   14:17 )
  Dr Reddy's Laboratories consolidated net profit rises 7.28% in the September 2025 quarter
 ( Results - Announcements 25-Oct-25   07:36 )
  Dr Reddys Laboratories Ltd soars 1.97%, rises for third straight session
 ( Hot Pursuit - 20-Oct-25   13:05 )
  Dr Reddys Laboratories Ltd drops for fifth straight session
 ( Hot Pursuit - 30-Sep-25   13:35 )
  Dr Reddys Laboratories schedules board meeting
 ( Corporate News - 23-Sep-25   09:47 )
  Dr Reddys Lab launches novel molecule, Tegoprazan
 ( Hot Pursuit - 17-Sep-25   08:22 )
  Dr. Reddy's allots 6,475 equity shares under ESOP
 ( Corporate News - 15-Sep-25   11:53 )
  Dr Reddy's Labs gets five USFDA observations for Bachupally unit
 ( Hot Pursuit - 13-Sep-25   12:41 )
Other Stories
  Safari Industries gains after Q2 PAT climbs 58% YoY to Rs 47 cr
  10-Nov-25   16:14
  Solar Industries India Q2 PAT rises 21% YoY to Rs 345 cr
  10-Nov-25   15:29
  Emami clocks PAT of Rs 148 crore in Q2; international business revenue up 8%
  10-Nov-25   15:27
  IT stocks rebound on value-buying
  10-Nov-25   15:13
  Transformers & Rectifiers India Ltd leads losers in 'A' group
  10-Nov-25   15:00
  Epigral slumps after dismal Q2 performance
  10-Nov-25   14:55
  Uno Minda spurts as Q2 profit rises 27% YoY
  10-Nov-25   14:47
  Kamat Hotels (India) Ltd leads losers in 'B' group
  10-Nov-25   14:45
  Volumes soar at HBL Engineering Ltd counter
  10-Nov-25   14:30
  Torrent Pharma jumps after Q2 profit rises 30% YoY
  10-Nov-25   14:27
Back Top